Evidence map›Paper›PMID 27353163›Full record

ArticleThe Journal of antibiotics2017

Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.

Zsolt Szűcs, Magdolna Csávás, Erzsébet Rőth, Anikó Borbás, Gyula Batta, Florent Perret, Eszter Ostorházi, Réka Szatmári, Evelien Vanderlinden, Lieve Naesens and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Developments in Glycopeptide Antibiotics.ACS infectious diseases · 2018
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zsolt SzűcsDepartment of Pharmaceutical Chemistry, University of Debrecen, Debrecen, Hungary.
Magdolna CsávásDepartment of Pharmaceutical Chemistry, University of Debrecen, Debrecen, Hungary.
Erzsébet RőthDepartment of Pharmaceutical Chemistry, University of Debrecen, Debrecen, Hungary.
Anikó BorbásDepartment of Pharmaceutical Chemistry, University of Debrecen, Debrecen, Hungary.
Gyula BattaDepartment of Organic Chemistry, University of Debrecen, Debrecen, Hungary.
Florent PerretICBMS-Equipe CSAp, Université Lyon 1, Villeurbanne, France.
Eszter OstorháziDepartment of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Réka SzatmáriDepartment of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Evelien VanderlindenRega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Lieve NaesensRega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Pál HerczeghDepartment of Pharmaceutical Chemistry, University of Debrecen, Debrecen, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of lipophilic teicoplanin pseudoaglycon derivatives, including alkyl-, aryl-, calixarene- and protected sugar-containing conjugates, were prepared using azide-alkyne click chemistry. Out of the conditions applied, the CuSO

Indexed as

Anti-Bacterial AgentsBacteriaDrug Resistance, BacterialMicrobial Sensitivity TestsMolecular StructureTeicoplaninTriazolesAnti-Bacterial AgentsTeicoplaninTriazoles

Identifiers

PMID27353163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.